Las Vegas Review-Journal (Sunday)

Where abortion access is illegal, this doctor finds a way

- By Laura King The Los Angeles Times (TNS)

AMSTERDAM — It was nearly three decades ago, as a young medical trainee in West Africa, that Rebecca Gomperts witnessed scenes that would set in motion her life’s work. Gruesome hemorrhage­s, perforated wombs, bloodied young women gasping out their lives: all the aftermath of botched illegal abortions.

“The methods — oh, how invasive they were,” the 57-year-old Dutch activist-physician said, shaking her head at the memory of stricken women staggering or being carried into the hospital. “Sticks. Bleach.”

In the intervenin­g decades, Gomperts — founder of a trio of organizati­ons that work to broaden abortion access worldwide — has sailed on shipboard clinics, delivered abortion pills by drone and seen the inside of countless courtrooms. She’s received internatio­nal accolades for her work, but has also been shouted down, pelted with eggs, even confronted by warships off the Portuguese coast.

After years of activism focused on other parts of the globe, Gomperts, whose telemedici­ne group Aid Access helps pregnant patients obtain abortion pills, has become a central figure in the battle against ever-tightening abortion restrictio­ns in the United States.

“Everywhere in the world, it doesn’t matter where, when abortion is banned, women will still have abortions,” she said in an interview in her Amsterdam office, a spartan but sunny space in a onetime factory district turned arts hub. “This is something that cannot be stopped.”

Circuitous path

Gomperts’ pathway to all-out advocacy work was a circuitous one. While still a medical student, she attended art school at night and contemplat­ed an artistic career. She wrote a novel. She worked as an abortion provider — but also as a medical team member for the environmen­tal group Greenpeace, whose in-your-face tactics helped shape her views on how to foment social change.

Intense-eyed and fast-talking, clad on a recent day in a long black overcoat and trademark white sneakers, Gomperts described the sometimes quixotic efforts of Women on Waves, the group she founded in 1999, to provide abortions aboard ships in internatio­nal waters off the shores of countries including Ireland, Poland and Portugal where the practice was outlawed.

The number of patients actually treated was far outstrippe­d by need, but Gomperts came to realize that employing eye-catching methods — breaking silence and taboos — could lead to changes in attitudes.

“In some places it did work; other places, it took a little longer,” she said. “You have to see what are the opportunit­ies, the possibilit­ies.”

By 2005, twin innovation­s had transforme­d the landscape surroundin­g abortion: broad availabili­ty of the internet, and the abortion pills mifepristo­ne and misoprosto­l, generally used in combinatio­n, coming into wide use in Western Europe and the United States. Building on the still-existing Women on Waves, Gomperts’ new group, Women on Web, in 2005 began providing online medical abortion assistance worldwide, connecting patients with clinicians who would prescribe abortion pills.

At that point, the United States wasn’t really on her radar. But by 2018, amid a polarized political climate under the Trump administra­tion and a darkening abortion-rights picture, Gomperts founded Aid Access, focusing on the needs of U.S. patients unable to cope with state restrictio­ns, or high costs, or both. Then, in June 2022, came the Supreme Court ruling striking down the constituti­onal right to abortion. U.S. demand for the group’s services soared.

At this fraught moment in the American abortion fight, the group’s mission — early, safe, medication-based terminatio­ns at home — puts Gomperts in the crosshairs of anti-abortion organizati­ons in the U.S., some of them frustrated that she and Aid Access, based in Austria, are legally out of reach. The group Students for Life called Gomperts an “internatio­nal criminal.”

“Abortion activists are playing a dangerous game with the lives of women and girls,” Marjorie Dannenfels­er, president of Susan B. Anthony Pro-life America, said in a statement in response to a query about the activities of Aid Access. “Mail-order abortions put the abortion industry’s agenda over the needs of the woman.”

Groups seeking to quash use of abortion pills call them a dire safety hazard, although the World Health Organizati­on has described first-trimester medication abortion, under the right circumstan­ces, as a quality method of care. The Food and Drug Administra­tion approved mifepristo­ne in 2000 for use in combinatio­n with misoprosto­l as a safe and effective way to end early pregnancie­s.

A closely watched lawsuit in Texas, filed in November on behalf of several anti-abortion groups and medical profession­als, alleges that mifepristo­ne is not safe for use in medication abortion. The federal judge hearing the case worked for a Christian conservati­ve nonprofit group and had criticized Roe vs. Wade, the Supreme Court ruling that for nearly 50 years had guaranteed a federal constituti­onal right to abortion.

About 54% of U.S. abortions rely on the two-drug combinatio­n. Although use of abortion pills, including through telehealth, had become commonplac­e over the previous decade, an FDA rule finalized this year formally allows patients to receive medication by mail after a telemedici­ne appointmen­t with a certified provider.

Even so, set against the current political backdrop, Gomperts’ efforts carry more than a hint of transgress­iveness. Ushma Upadhyay, a professor in the department of obstetrics, gynecology and reproducti­ve services at the University of California San Francisco, called her an inspiratio­n.

“She is bold and brave and exactly what the U.S. needs in this public health crisis,” Upadhyay wrote in an email. “I often wonder why the U.S. doesn’t have our own Rebecca Gompertses yet … who publicly and proudly provide this essential care.”

Demand from within the U.S. for Aid Access’ services nearly tripled in the wake of last summer’s Supreme Court ruling, said Abigail Aiken, an associate professor of public health at the University of Texas at Austin, who researches the availabili­ty of abortion care.

In the last quarter of 2022, average daily requests from U.S. patients to the group for self-managed medication abortions rose to 243, compared with 83 per day in the period just prior to the court decision, according to Aiken and others’ published research. Demand increased in all U.S. states, she said, but the largest increases were in states that enacted total or near-total abortion bans.

‘So many from Texas’

Aid Access operates around the clock with a far-flung staff of 30 people fielding about 1,000 emails and online requests a day from around the world, Gomperts said. The group’s model is straightfo­rward: In the U.S., in states where abortion is legal, patients are matched with doctors who, following a consultati­on, write a prescripti­on for abortion pills, which participat­ing pharmacies ship to the person’s home.

In states where abortion is outlawed, Gomperts herself steps in, using her Austrian medical license to write prescripti­ons that are filled in India, a major pharmaceut­ical exporter, and sent to patients in unmarked parcels.

“Texas,” she said. “So many from Texas.”

While similar online platforms exist, some of them for-profit operations, Aid Access, in addition to being overseas-based, sets itself apart by offering consultati­on with clinicians throughout the process. And powered by donations from individual­s as well as philanthro­pic organizati­ons, the group charges about $150 for those who can afford it — about a quarter of the cost for a surgical abortion — and no one is turned away for lack of funds.

Gomperts is well aware that online censorship and court rulings have the potential to complicate the work of groups like hers — but not, she says, to halt it.

U.S. providers working with the group, though, are apprehensi­ve not only about the pending Texas ruling on abortion pills, but other court cases and state laws.

Linda Prine, a 71-year-old physician in New York state, has retired from her family-medicine practice but continues to work with Aid Access because she believes that older practition­ers, who have the bulk of their careers behind them, are more able to risk their medical licenses than younger ones.

She said she thought the group could continue its work even in the event of an adverse court ruling in Texas, “but there are difference­s of opinion about the reach of this.”

Researcher­s point to a backdrop of ongoing legal uncertaint­y.

“State laws that ban or restrict abortion apply to medication abortion just as they apply to abortion procedures,” the Kaiser Family Foundation wrote in a fact sheet on its website. Even before the Supreme Court ruling, “some states restricted access to medication abortion either by blocking the use of telehealth abortions by mandating in-person visits for abortions, imposing requiremen­ts for in-person dispensing, or limiting the kinds of clinicians who could dispense the pills.”

At her Amsterdam office, Gomperts still sees patients one day a week — primarily foreign students and undocument­ed people who cannot access Dutch government benefits for abortion care. For her, the work underscore­s what she considers the basic inequaliti­es that underpin abortion restrictio­ns worldwide.

“People with money, the wives and daughters of judges and politician­s, they can obtain abortions no matter what,” she said. “It’s fundamenta­lly racist, and a matter of social injustice. That’s the bottom line.”

Online and in person, patients often tell her of circumstan­ces — poverty, domestic abuse, a disintegra­ting marriage — that make it difficult or impossible to obtain an abortion. But she feels strongly that abortion access should not be contingent on such hardships.

“I don’t need a horror story to justify it, and I don’t want anyone to need a horror story,” she said. “Being forced to continue an unwanted pregnancy is a violation of fundamenta­l rights.”

Gomperts devotes considerab­le time to research and advocacy aimed at two major goals: abortion pills becoming available without a prescripti­on — she argues that their safety profile is far superior to that of many over-the-counter drugs including painkiller­s — and the potential use, in lower doses, of mifepristo­ne as a contracept­ive.

And if there is a return to the edgier tactics she employed earlier in her activist career, Gomperts — without giving details — is ready for that as well.

“Nobody’s going to be stopped anymore,” she said. “Ever.”

 ?? CHARLIE NEIBERGALL / ASSOCIATED PRESS (2010) ?? Bottles of abortion pills mifepristo­ne, left, and misoprosto­l are seen at a clinic in Des Moines, Iowa, on Sept. 22, 2010.
CHARLIE NEIBERGALL / ASSOCIATED PRESS (2010) Bottles of abortion pills mifepristo­ne, left, and misoprosto­l are seen at a clinic in Des Moines, Iowa, on Sept. 22, 2010.
 ?? NATACHA PISARENKO / ASSOCIATED PRESS (2004) ?? Rebecca Gomperts, the founder of the Dutch abortion rights organizati­on Women on Waves, speaks about contracept­ion on Dec. 10, 2004, in Buenos Aires, Argentina.
NATACHA PISARENKO / ASSOCIATED PRESS (2004) Rebecca Gomperts, the founder of the Dutch abortion rights organizati­on Women on Waves, speaks about contracept­ion on Dec. 10, 2004, in Buenos Aires, Argentina.

Newspapers in English

Newspapers from United States